Emerging Company Profile
Sofinnova’s Papiernik, Costa and Roche alum Garibaldi carve orphan neurology play Noema out of the pharma’s assets
Emerging Company Profile: Noema emerges from stealth with $59M to develop four clinical neurology programs in-licensed from Roche
Noema has emerged from stealth with $59M in a series A led by Sofinnova Partners and Polaris to develop four clinical neurology programs in-licensed from Roche.
Dec 2, 2020 | 2:08 AM GMT
Five years after Sofinnova Partners’ Antoine Papiernik first connected with Roche neurology veteran George Garibaldi, the